Amylin Pharmaceuticals, Inc.

Sunil Bhavsar

Andrew A Young

Nigel Robert Arnold Beeley

Kathryn Susan Prickett

Bronislava Gedulin

Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed.

Exendin and exendin agonists for eating disorders

Exendins and exendin agonists for weight reduction and obesity

Exendin agonist analogs to treat diabetes

Use of exendins and agonists thereof to treat diabetes

Pharmaceutical compositions containing exendins

Provided are methods for lowering plasma lipid in an individual in need of or desirous of lowering plasma lipid by administering an amount of an exendin or an exendin agonist analog effective to lower plasma lipid.

Use of exendins and agonists thereof for lowering plasma lipid

Exendins, exendin agonists, and methods for their use

Use of exendins for the reduction of food intake

Growing community of inventors

San Diego, CA, United States of America

Sunil Bhavsar